Sichenzia Ross Ference Kesner LLP Represents Cannabinoid Based Therapeutics Company in $12.3 Million Private Placement Led by Tuatara Capital Fund I, Ltd.
Press Release – New York, NY – March 2, 2017 – Securities and corporate law firm Sichenzia Ross Ference Kesner LLP is pleased to announce that the firm has represented a cannabinoid based life sciences corporation whose technology is designed to synthetically produce medically beneficial cannabinoids without utilizing the actual cannabis plant for the customized treatment of disease.
Last year, Tuatara and its affiliates invested $7.0 million in a Series A Financing for the company. The Sichenzia Ross Ference Kesner LLP team was led by partners Darrin M. Ocasio and Arthur Marcus and associate S. Ashley Jaber. Sichenzia Ross Ference Kesner LLP is a leader in the representation of cannabis related companies.
- Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in $6.43 Million Public Offering of Common Stock - July 8, 2020
- Two Bright Sides of Estate Planning During COVID-19 - July 1, 2020
- Sichenzia Ross Ference LLP Represents Aegis Capital in $5.4 Million Public Offering of Avinger, Inc. Common Stock - June 26, 2020